» Authors » Daniel Gonzalez-Moreno

Daniel Gonzalez-Moreno

Explore the profile of Daniel Gonzalez-Moreno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 8
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vazquez-Sanchez S, Blasco A, Fernandez-Corredoira P, Cantolla P, Mercado-Garcia E, Rodriguez-Sanchez E, et al.
J Pathol . 2025 Jan; 265(3):342-356. PMID: 39815421
Ischaemic heart disease (IHD) remains a major cause of death and morbidity. Klotho is a well-known anti-ageing factor with relevant cardioprotective actions, at least when renal dysfunction is present, but...
2.
Gonzalez-Lafuente L, Mercado-Garcia E, Vazquez-Sanchez S, Gonzalez-Moreno D, Bosca L, Fernandez-Velasco M, et al.
Nefrologia (Engl Ed) . 2024 Nov; 44(6):818-829. PMID: 39616092
Background And Objective: In acute kidney injury (AKI), a strong inflammatory component is activated in response to the renal damage, and one of the main mediators behind this process is...
3.
Vega-Martin E, Gonzalez-Moreno D, Sanz-Gomez M, Guzman-Aguayo A, Manzano-Lista F, Schulz A, et al.
Int J Mol Sci . 2023 Dec; 24(23). PMID: 38069331
Perirenal adipose tissue (PRAT) surrounding the kidney is emerging as a player and novel independent risk factor in diabetic kidney disease (DKD); DKD is a complication of diabetes and is...
4.
Gonzalez-Blazquez R, Gil-Ortega M, Alcala M, Gonzalez-Moreno D, Viana M, Chowen J, et al.
Acta Physiol (Oxf) . 2023 Aug; 239(3):e14023. PMID: 37553856
Aim: In addition to functioning as an energy sensor switch, AMPK plays a key role in the maintenance of cardiovascular homeostasis. However, obesity disrupts AMPK signaling, contributing to endothelial dysfunction...
5.
Alvarez-Gallego F, Gonzalez-Blazquez R, Gil-Ortega M, Somoza B, Calderon-Dominguez M, Moratinos J, et al.
Biofactors . 2023 Jun; 49(6):1106-1120. PMID: 37286331
The angiotensin II type 2 receptor (AT2R) exerts vasorelaxant, anti-inflammatory, and antioxidant properties. In obesity, its activation counterbalances the adverse cardiovascular effects of angiotensin II mediated by the AT1R. Preliminary...
6.
Manzano-Lista F, Sanz-Gomez M, Gonzalez-Moreno D, Vega-Martin E, Gil-Ortega M, Schulz A, et al.
Int J Mol Sci . 2023 Jan; 24(1). PMID: 36613483
Arterial stiffness is a major vascular complication of chronic kidney disease (CKD). The development of renal damage, hypertension, and increased pulse wave velocity (PWV) in CKD might be associated with...